✦ LIBER ✦

Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers

✍ Scribed by R. Mäntylä; P. Männistö; S. Nykänen; A. Koponen; U. Lamminsivu

Publisher: Springer
Year: 1983
Tongue: English
Weight: 349 KB
Volume: 24
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00613822

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of intravenous timolol

Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers

✍ J. Anders Vedin; J. K. Kristianson; C. -E. Wilhelmsson 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 482 KB

No clinically relevant pharmacokinetic a

No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers

✍ Rebecca Spence; Arun Mandagere; Brooke Harrison; Christopher Dufton; Ramesh Boin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Ambrisentan is a nonsulfonamide, ET(A)-selective endothelin receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension (PAH), and tadalafil is a phosphodiesterase type 5 (PDE-5) inhibitor under investigation for treatment of PAH. Due to the potential combination use, the

The pharmacokinetics of olsalazine sodiu

The pharmacokinetics of olsalazine sodium in healthy volunteers after a single i.v. dose and after oral doses with and without food

✍ E. M. Ryde; N. -O. Ahnfelt 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 879 KB

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of filgrastim

✍ Phillippe van der Auwera; Erich Platzer; Z.-X. Xu; Rainer Schulz; Olivier Feugea 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views